Among those who suffer from depression, the dual inabilities to experience enjoyment in things once pleasurable and to physically motivate oneself - to meet challenges, or even to get out of bed in the morning - have been documented for decades, though it has been mysterious why these very...
Micromet, Inc. (Nasdaq: MITI) announced the presentation of updated results from a Phase 1 trial of the Company's lead product candidate blinatumomab (MT103) in patients with relapsed non-Hodgkin's lymphoma (NHL). A high objective response rate was maintained among patients treated with...
Medistem Inc. (PINKSHEETS: MEDS) reported today a recent publication in the peer reviewed journal International Archives of Medicine describing a 74 year old heart failure patient treated with the company's endometrial regenerative cell (ERC) product in November 2007. The patient's ejection...